PE(18:1/20:5)

Metabolite details

Identifier

LFGBKOUQHCWBQI-BZGLIJSBSA-N

InChI Key

LFGBKOUQHCWBQI-BZGLIJSBSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate

Preferred name

PE(18:1/20:5)

INN name

—

Synonym

—

ChEBI

CHEBI:176743

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.

Observed in differential profiles

• Wild_type_vs_hfq
• Control_vs_AONFH_Stage_III_IV
• Control_vs_Exercise
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female